Our mission is to generate new therapies for cardiovascular-metabolic disorders, and reverse unfavorable aspects of aging.

- What's new -

July, 2021

Frontiers in Cardiovascular Medicine; IF 6.05! Awesome!!

https://www.frontiersin.org/journals/cardiovascular-medicine/sections/cardiovascular-metabolism#

April, 2021

Ippei Shimizu appointed as a leader of U45-ISHR Japanese section.

(International Society of Heart Research).

https://www.u45ishr.com/

April, 2021

We moved to Juntendo University, Tokyo, Japan.

March, 2021
Congrats!
Winner; Yung Ting Hsiao; YIA competition for International Students, 84th Annual Scientific Meeting of Japanese Circulation Society 2021 (JCS2021)

March 2021

Published
Hsiao
YT*, Shimizu I*,**, Wakasugi T, Jiao S, Watanabe T, Yoshida Y, Ikegami R, Hayashi Y, Suda M, Katsuumi G, Nakao M, Ozawa T, Kashimura T, Ozaki K, Hanawa H, Minamino T**. Cardiac Mitofusin-1 is Reduced in Non-responding Patients with Idiopathic Dilated Cardiomyopathy.  Sci Rep. , Mar24; 11(1):6722, 2021. *Co-first author, **Co-corresponding author